{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T01:34:15Z","timestamp":1789263255045,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,9]]},"DOI":"10.7759\/cureus.64181","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T19:48:28Z","timestamp":1720554508000},"source":"Crossref","is-referenced-by-count":2,"title":["Chemotherapy Release From Bortezomib-Impregnated Polymethylmethacrylate-Coated Intramedullary Nails: A Novel In Vitro Study for a Local Chemotherapy Delivery Device"],"prefix":"10.7759","author":[{"given":"Emily","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela C","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113519","article-title":"Vincristine- and bortezomib-induced neuropathies - from bedside to bench and back","volume":"336","author":"Geisler S","year":"2021","unstructured":"Geisler S. Vincristine- and bortezomib-induced neuropathies - from bedside to bench and back. Exp Neurol. 2021, 336:113519. 10.1016\/j.expneurol.2020.113519","journal-title":"Exp Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.b.33931","article-title":"Drug release as a function of bioactivity, incubation regime, liquid, and initial load: release of bortezomib from calcium phosphate-containing silica\/collagen xerogels","volume":"106","author":"Kruppke B","year":"2018","unstructured":"Kruppke B, Hose D, Schnettler R, Seckinger A, R\u00f6\u00dfler S, Hanke T, Heinemann S. Drug release as a function of bioactivity, incubation regime, liquid, and initial load: release of bortezomib from calcium phosphate-containing silica\/collagen xerogels. J Biomed Mater Res B Appl Biomater. 2018, 106:1165-73. 10.1002\/jbm.b.33931","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"ref3","article-title":"The preclinical discovery and development of bortezomib for the treatment of mantle cell lymphoma","volume":"12","author":"Arkwright R","year":"2016","unstructured":"Arkwright R, Pham TM, Zonder JA, et al.. The preclinical discovery and development of bortezomib for the treatment of mantle cell lymphoma. Expert Opin Drug Discov. 2016, 12:225-35.","journal-title":"Expert Opin Drug Discov"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2013.815728","article-title":"Targeting the ubiquitin-proteasome system for cancer therapy","volume":"17","author":"Shen M","year":"2013","unstructured":"Shen M, Schmitt S, Buac D, Dou QP. Targeting the ubiquitin-proteasome system for cancer therapy. Expert Opin Ther Targets. 2013, 17:1091-108. 10.1517\/14728222.2013.815728","journal-title":"Expert Opin Ther Targets"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2017.1268596","article-title":"The preclinical discovery and development of bortezomib for the treatment of mantle cell lymphoma","volume":"12","author":"Arkwright R","year":"2017","unstructured":"Arkwright R, Pham TM, Zonder JA, Dou QP. The preclinical discovery and development of bortezomib for the treatment of mantle cell lymphoma. Expert Opin Drug Discov. 2017, 12:225-35. 10.1080\/17460441.2017.1268596","journal-title":"Expert Opin Drug Discov"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2013.11.021","article-title":"The combination of proteasome inhibitors bortezomib and gambogic acid triggers synergistic cytotoxicity in vitro but not in vivo","volume":"224","author":"Liu N","year":"2014","unstructured":"Liu N, Huang H, Xu L, et al.. The combination of proteasome inhibitors bortezomib and gambogic acid triggers synergistic cytotoxicity in vitro but not in vivo. Toxicol Lett. 2014, 224:333-40. 10.1016\/j.toxlet.2013.11.021","journal-title":"Toxicol Lett"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/172458","article-title":"Mechanism of action of bortezomib and the new proteasome inhibitors on myeloma cells and the bone microenvironment: impact on myeloma-induced alterations of bone remodeling","volume":"2015","author":"Accardi F","year":"2015","unstructured":"Accardi F, Toscani D, Bolzoni M, Dalla Palma B, Aversa F, Giuliani N. Mechanism of action of bortezomib and the new proteasome inhibitors on myeloma cells and the bone microenvironment: impact on myeloma-induced alterations of bone remodeling. Biomed Res Int. 2015, 2015:172458. 10.1155\/2015\/172458","journal-title":"Biomed Res Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9440(10)61708-7","article-title":"New insights into the role of nuclear factor-kappaB in cell growth regulation","volume":"159","author":"Chen F","year":"2001","unstructured":"Chen F, Castranova V, Shi X. New insights into the role of nuclear factor-kappaB in cell growth regulation. Am J Pathol. 2001, 159:387-97. 10.1016\/s0002-9440(10)61708-7","journal-title":"Am J Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/1078155214533367","article-title":"Tolerability of Velcade (Bortezomib) subcutaneous administration using a maximum volume of 3\u2009mL per injection site","volume":"21","author":"Ng P","year":"2015","unstructured":"Ng P, Incekol D, Lee R, et al.. Tolerability of Velcade (Bortezomib) subcutaneous administration using a maximum volume of 3\u2009mL per injection site. J Oncol Pharm Pract. 2015, 21:285-92. 10.1177\/1078155214533367","journal-title":"J Oncol Pharm Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.12.013","article-title":"Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment","volume":"68","author":"Yang H","year":"2021","unstructured":"Yang H, Chen X, Li K, et al.. Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment. Semin Cancer Biol. 2021, 68:105-22. 10.1016\/j.semcancer.2019.12.013","journal-title":"Semin Cancer Biol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar SV","year":"2022","unstructured":"Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022, 97:1086-107. 10.1002\/ajh.26590","journal-title":"Am J Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37670","article-title":"Chemotherapy may obviate prophylactic femoral nail surgery for multiple myeloma patients with high Mirels' score lesions and impending pathological hip fracture","volume":"15","author":"Divekar O","year":"2023","unstructured":"Divekar O, Ajayi B, Barkham B, et al.. Chemotherapy may obviate prophylactic femoral nail surgery for multiple myeloma patients with high Mirels' score lesions and impending pathological hip fracture. Cureus. 2023, 15:e37670. 10.7759\/cureus.37670","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-27-11","article-title":"Effect of pathologic fractures on survival in multiple myeloma patients: a case control study","volume":"27","author":"Sonmez M","year":"2008","unstructured":"Sonmez M, Akagun T, Topbas M, et al.. Effect of pathologic fractures on survival in multiple myeloma patients: a case control study. J Exp Clin Cancer Res. 2008, 27:11. 10.1186\/1756-9966-27-11","journal-title":"J Exp Clin Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1097\/00003086-198912000-00027","article-title":"Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures","volume":"249","author":"Mirels H","year":"1989","unstructured":"Mirels H. Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthopaed Related Res. 1989, 249:256-64.","journal-title":"Clin Orthopaed Related Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00264-021-05087-1","article-title":"A pituitary cup biopsy is more accurate than reamings for histological diagnosis of intramedullary lesions during nailing of impending and pathologic fractures: a retrospective matched cohort analysis","volume":"45","author":"Ononuju U","year":"2021","unstructured":"Ononuju U, Hamilton DA, Washington A, Vaidya R. A pituitary cup biopsy is more accurate than reamings for histological diagnosis of intramedullary lesions during nailing of impending and pathologic fractures: a retrospective matched cohort analysis. Int Orthop. 2021, 45:2735-40. 10.1007\/s00264-021-05087-1","journal-title":"Int Orthop"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1302\/2058-5241.1.000008","article-title":"Treatment of pathological fractures of the long bones","volume":"1","author":"Willeumier JJ","year":"2016","unstructured":"Willeumier JJ, van der Linden YM, van de Sande MA, Dijkstra PD. Treatment of pathological fractures of the long bones. EFORT Open Rev. 2016, 1:136-45. 10.1302\/2058-5241.1.000008","journal-title":"EFORT Open Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2015.56.2.460","article-title":"Surgical treatment of pathological fractures occurring at the proximal femur","volume":"56","author":"Choy WS","year":"2015","unstructured":"Choy WS, Kim KJ, Lee SK, Yang DS, Jeung SW, Choi HG, Park HJ. Surgical treatment of pathological fractures occurring at the proximal femur. Yonsei Med J. 2015, 56:460-5. 10.3349\/ymj.2015.56.2.460","journal-title":"Yonsei Med J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.otsr.2016.11.001","article-title":"Metastatic fractures of long limb bones","volume":"103","author":"Anract P","year":"2017","unstructured":"Anract P, Biau D, Boudou-Rouquette P. Metastatic fractures of long limb bones. Orthop Traumatol Surg Res. 2017, 103:S41-51. 10.1016\/j.otsr.2016.11.001","journal-title":"Orthop Traumatol Surg Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-016-5069-8","article-title":"Is it appropriate to treat sarcoma metastases with intramedullary nailing?","volume":"475","author":"Moon BS","year":"2017","unstructured":"Moon BS, Dunbar DJ, Lin PP, Satcher RL, Bird JE, Lewis VO. Is it appropriate to treat sarcoma metastases with intramedullary nailing?. Clin Orthop Relat Res. 2017, 475:212-7. 10.1007\/s11999-016-5069-8","journal-title":"Clin Orthop Relat Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1586\/17474086.2013.874943","article-title":"Management of bone disease in multiple myeloma","volume":"7","author":"Terpos E","year":"2014","unstructured":"Terpos E, Berenson J, Raje N, Roodman GD. Management of bone disease in multiple myeloma. Expert Rev Hematol. 2014, 7:113-25. 10.1586\/17474086.2013.874943","journal-title":"Expert Rev Hematol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5435\/00124635-201005000-00006","article-title":"Polymethylmethacrylate: properties and contemporary uses in orthopaedics","volume":"18","author":"Jaeblon T","year":"2010","unstructured":"Jaeblon T. Polymethylmethacrylate: properties and contemporary uses in orthopaedics. J Am Acad Orthop Surg. 2010, 18:297-305. 10.5435\/00124635-201005000-00006","journal-title":"J Am Acad Orthop Surg"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/BOT.0000000000002453","article-title":"Antibiotic cement-coated interlocked intramedullary nails for the treatment of infected nonunion after intramedullary nailing","volume":"37","author":"Zalikha AK","year":"2023","unstructured":"Zalikha AK, Sayeed Z, Stine SA, Bray R, Vaidya R. Antibiotic cement-coated interlocked intramedullary nails for the treatment of infected nonunion after intramedullary nailing. J Orthop Trauma. 2023, 37:e1-6. 10.1097\/BOT.0000000000002453","journal-title":"J Orthop Trauma"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/OI9.0000000000000298","article-title":"Antibiotic cement nails manufactured with threaded rods or cannulated intramedullary nails are better than those made with guidewires and do not debond","volume":"7","author":"Bray R","year":"2024","unstructured":"Bray R, Zalikha AK, Ren E, Nasr K, Vaidya R. Antibiotic cement nails manufactured with threaded rods or cannulated intramedullary nails are better than those made with guidewires and do not debond. OTA Int. 2024, 7:e298. 10.1097\/OI9.0000000000000298","journal-title":"OTA Int"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-009-0847-1","article-title":"Hand-mixed and premixed antibiotic-loaded bone cement have similar homogeneity","volume":"467","author":"McLaren AC","year":"2009","unstructured":"McLaren AC, Nugent M, Economopoulos K, Kaul H, Vernon BL, McLemore R. Hand-mixed and premixed antibiotic-loaded bone cement have similar homogeneity. Clin Orthop Relat Res. 2009, 467:1693-8. 10.1007\/s11999-009-0847-1","journal-title":"Clin Orthop Relat Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00264-018-4135-0","article-title":"Altering polymerization temperature of antibiotic-laden cement can increase porosity and subsequent antibiotic elution","volume":"42","author":"Sundblad J","year":"2018","unstructured":"Sundblad J, Nixon M, Jackson N, Vaidya R, Markel D. Altering polymerization temperature of antibiotic-laden cement can increase porosity and subsequent antibiotic elution. Int Orthop. 2018, 42:2627-32. 10.1007\/s00264-018-4135-0","journal-title":"Int Orthop"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3928\/01477447-20170120-01","article-title":"Elution profiles of two methods of antibiotic tibial nail preparations","volume":"40","author":"Karek MR","year":"2017","unstructured":"Karek MR, Jackson NM, Flynn JC, Vaidya R, Markel DC. Elution profiles of two methods of antibiotic tibial nail preparations. Orthopedics. 2017, 40:e436-42. 10.3928\/01477447-20170120-01","journal-title":"Orthopedics"},{"key":"ref27","unstructured":"Antibiotic Cement Mold Preparation. (2019). Accessed. Feb 18, 2024\u00a0: https:\/\/www.youtube.com\/watch?v=mJvuazbPsn0."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2016.11.122","article-title":"Polypropyleneimine and polyamidoamine dendrimer mediated enhanced solubilization of bortezomib: comparison and evaluation of mechanistic aspects by thermodynamics and molecular simulations","volume":"72","author":"Chaudhary S","year":"2017","unstructured":"Chaudhary S, Gothwal A, Khan I, Srivastava S, Malik R, Gupta U. Polypropyleneimine and polyamidoamine dendrimer mediated enhanced solubilization of bortezomib: comparison and evaluation of mechanistic aspects by thermodynamics and molecular simulations. Mater Sci Eng C Mater Biol Appl. 2017, 72:611-9. 10.1016\/j.msec.2016.11.122","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"ref29","article-title":"The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells","volume":"61","author":"Hideshima T","year":"2001","unstructured":"Hideshima T, Richardson P, Chauhan D, et al.. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res. 2001, 61:3071-6.","journal-title":"Cancer Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1039\/D1MA00188D","article-title":"A slow and sustained release of methotrexate (MTX) from a new polymeric dicalcium phosphate dehydrate cement (P-DCPD)","volume":"2","author":"Vaidya R","year":"2021","unstructured":"Vaidya R, Ren E, Shi T, Gardia A, Ren W. A slow and sustained release of methotrexate (MTX) from a new polymeric dicalcium phosphate dehydrate cement (P-DCPD). Materials Adv. 2021, 2:10.1039\/D1MA00188D","journal-title":"Materials Adv"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/ans.15463","article-title":"Ambient theatre temperature and cement setting time in total knee arthroplasty","volume":"89","author":"Elliott R","year":"2019","unstructured":"Elliott R, Regazzola G, Bruce WJ. Ambient theatre temperature and cement setting time in total knee arthroplasty. ANZ J Surg. 2019, 89:1424-7. 10.1111\/ans.15463","journal-title":"ANZ J Surg"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/00003086-200101000-00034","article-title":"The clinical significance of vacuum mixing bone cement","author":"Geiger MH","year":"2001","unstructured":"Geiger MH, Keating EM, Ritter MA, Ginther JA, Faris PM, Meding JB. The clinical significance of vacuum mixing bone cement. Clin Orthop Relat Res. 2001, 258-66. 10.1097\/00003086-200101000-00034","journal-title":"Clin Orthop Relat Res"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620x.81b3.9167","article-title":"Cytotoxic effect of methotrexate and its solvent on osteosarcoma cells in vitro","volume":"81","author":"Decker S","year":"1999","unstructured":"Decker S, Winkelmann W, Nies B, van Valen F. Cytotoxic effect of methotrexate and its solvent on osteosarcoma cells in vitro. J Bone Joint Surg Br. 1999, 81:545-51. 10.1302\/0301-620x.81b3.9167","journal-title":"J Bone Joint Surg Br"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.3087","article-title":"Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy","volume":"27","author":"Richardson PG","year":"2009","unstructured":"Richardson PG, Xie W, Mitsiades C, et al.. Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy. J Clin Oncol. 2009, 27:3518-25. 10.1200\/JCO.2008.18.3087","journal-title":"J Clin Oncol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-010-1283-3","article-title":"Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma","volume":"67","author":"Reece DE","year":"2011","unstructured":"Reece DE, Sullivan D, Lonial S, et al.. Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma. Cancer Chemother Pharmacol. 2011, 67:57-67. 10.1007\/s00280-010-1283-3","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref36","article-title":"Subcutaneous administration of anticancer agents","volume":"34","author":"Leveque D","year":"2014","unstructured":"Leveque D. Subcutaneous administration of anticancer agents. Anticancer Res. 2014, 34:1579-86.","journal-title":"Anticancer Res"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70081-X","article-title":"Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study","volume":"12","author":"Moreau P","year":"2011","unstructured":"Moreau P, Pylypenko H, Grosicki S, et al.. Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study. Lancet Oncol. 2011, 12:431-40. 10.1016\/S1470-2045(11)70081-X","journal-title":"Lancet Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/244361-chemotherapy-release-from-bortezomib-impregnated-polymethylmethacrylate-coated-intramedullary-nails-a-novel-in-vitro-study-for-a-local-chemotherapy-delivery-device","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T19:48:33Z","timestamp":1720554513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/244361-chemotherapy-release-from-bortezomib-impregnated-polymethylmethacrylate-coated-intramedullary-nails-a-novel-in-vitro-study-for-a-local-chemotherapy-delivery-device"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":37,"URL":"https:\/\/doi.org\/10.7759\/cureus.64181","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,9]]}}}